Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2022

5-year impact of new registered indications on the ESMO-MCBS

ICI landscape in solid tumours: what are the scores, are there differences and why?

Date

09 Sep 2022

Session

5-year impact of new registered indications on the ESMO-MCBS

Topics

Cancer Care Equity Principles and Health Economics

Tumour Site

Presenters

Luís Castelo-Branco

Authors

L. Castelo-Branco

Author affiliations

  • ESMO - European Society for Medical Oncology, 6900 - Lugano/CH

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.